Thermo Fisher Scientific introduces One Lambda HybriType HLA Plus Flex Typing kit
Thermo Fisher Scientific has introduced the One Lambda HybriType HLA Plus Typing Flex kit, an next generation sequencing (NGS) hybrid capture assay featuring a probe-based design that optimizes read balance and uniformity, potentially mitigating allele dropout.
The One Lambda HybriType assay is designed to provide flexibility in testing configuration and coverage, supporting human leukocyte antigen (HLA) Class I (4 field) and Class II (3 field) genotyping analysis across various sample types, including whole blood and buccal swabs.
Its flexible content and extensive gene coverage may minimize ambiguity, delivering results with ≥99.8% concordance. The streamlined workflow, taking less than 5.5 hours with under 2.5 hours of hands-on time, combined with One Lambda TypeStream Visual NGS Software, enables rapid automated analysis.
For Research Use Only. Not for use in diagnostic procedures.
